Tammam Hanna, MD, an orthopedic surgeon in Lubbock, Texas, performed the first U.S. clinical case of TYBR Health’s B3 Gel system, according to a Jan. 5 news release.
B3 Gel is a collagen-based tissue protector derived from extracellular matrix and conforms to the tissue surface.
“In a complex second-stage flexor tendon reconstruction—where balancing tissue protection with early rehabilitation is critical — I applied B3 GEL directly over the repair,” Dr. Hanna said in the release. “The gel set within minutes, maintained excellent visualization, and allowed smooth tendon gliding without restricting motion. I subsequently used it in two additional flexor tendon repair cases, and across these early cases I observed consistently favorable early range of motion, minimal stiffness, and no complications — findings that are very encouraging in this patient population.”
